Cancer of the(cholangiocarcinoma) is relatively rare and can develop in the intra- or extrahepatic bile ducts (in- or outside of the liver). This cancer is mainly an . Bile duct cancer usually arises sporadically, but some risk factors have been identified, such as primary sclerosing cholangitis, which is a bile duct inflammation that gradually prevents the flow of bile, bile duct cysts, some parasitic infections, hepatitis C, and certain chemicals.
Symptoms of bile duct cancer
Cholangiocarcinoma can injure the bile ducts at several levels: in the liver tissue, at the level of their exit from the liver (the most common) or at their junction with the. The disease can be completely asymptomatic or manifest with jaundice, resulting from obstruction of the bile ducts.
The diagnosis is made by CT scan, MRI, and/or by PET-scan. Gastroenterology Division.examination of the bile ducts can also confirm the diagnosis and place a to remove the obstruction in the bile ducts. The stent placement is performed by the
Treatment of bile duct cancer depends on its stage
Treatment of bile duct cancer is tailored to the stage and location of the tumor. Each cancer case is discussed at a weekly multidisciplinary meeting named. In some cases, the curative treatment is based on surgical removal, combined with chemotherapy. In cases of advanced tumors, palliative surgical measures and chemotherapy/radiotherapy may be proposed.
INFO + Echo-endoscopy (FR)
INFO + The Digestive Cancers Program